-
Jim QIU
Equity Partner / Shanghai
-
Tel +86-21-6061-3666
Email jimqiu@zhonglun.com
-
Practices

Compliance & Investigation, Investment/M&A & Corporate Governance, Private Equity & Investment Funds
-
Industries

Pharmaceuticals & Life Sciences, Healthcare, Telecommunications & Internet
Jim QIU
Mr. Jim Qiu specializes in compliance within the life sciences and healthcare sphere. He has provided compliance and risk management services to various enterprises in a wide range of transactions, boasting extensive practice experience in enterprise compliance management and operation, analysis, control, and mitigation of compliance risks, compliance review, compliance investigation and due diligence, as well as consultation and support on legal proceedings against compliance violation domestically and overseas.
Mr. Qiu's track record notably includes long-term legal services to many multinational and domestic Fortune 500 companies operating in pharmaceutical, medical device, pharmaceutical service, and online medical sectors, and his practice covers the entire lifecycles of healthcare and life science businesses, such as industry access and supervision, licensing transaction, product R&D and clinical compliance, healthcare regulatory compliance, product marketing, academic activities, HCP interaction, pharmacovigilance, medical device adverse events, online healthcare, medical ecommerce, doctor-patient conflict, etc. In addition to the healthcare sector, Mr. Qiu and his team also have substantial expertise and experience in the fields of health food, cosmetics, food for specific medical purposes, infant formula food, pet food (including pet prescription food), etc.
Alongside his legal practice, Mr. Qiu acts as the Director of Professional Committee of Pharmaceutical and Healthcare Affairs of Shanghai Bar Association, a long-term external counsel of all the medical associations and organizations in Shanghai, including Shanghai Medical Association, as well as a special columnist for the compliance section of LexisNexis, a globally well-known publishing organization.
Representative Matters
Compliance and Regulation in Medical Healthcare Industry
Provided legal and compliance services to Sanofi on long-term basis for its China operations, covering both general matters and specific projects
Advised Merck Sharp & Dohme on long-term basis on its China operations, covering compliance and general matters
Provided legal services for the R&D segment of BeiGene on long-term basis
Provided legal services, including regulatory compliance advice, to Roche with respect to its digital marketing business
Assisted United Imaging in its daily compliance affairs and contract matters
Provided legal and compliance advisory services to Stryker on long-term basis in connection with its daily operations
Provided long-term legal advice to Smith & Nephew for daily compliance-related affairs
Provided retainer-based legal advisory service to Hoya/Pentax for its China operations, covering both general compliance and specific projects
Provided legal and compliance service on a retainer basis to the healthcare division of ByteDance
Provided legal and compliance advisory services on a retainer basis to Tencent Healthcare Affairs Division
Provided legal and compliance services on a retainer basis to DXY on its China operations
Provided comprehensive services on long-term basis to the Management Office of All Shanghai Medical Associations (including Shanghai Medical Association, Shanghai Physician Association, Shanghai Chinese Medicine Association, Shanghai Nursing Association, etc.)
Assisted a US-based global pharmaceutical company on long-term basis in a number of cases regarding the adverse events across the nation
Represented a US-based pharmaceutical company in a drug quality dispute over adverse drug reactions and medical products
Represented a multinational pharmaceutical company in a lawsuit over indemnification disputes against subjects in multi-center clinical trials
Provided specific compliance advice to a multinational pharmaceutical company on the bid evaluation matters for centralized volume-based procurement of medicines
Provided specific compliance advice to a renowned Israeli medical devices company on the marketing pathway in China of an innovative drug and medical device combined product
Represented a Europe-based international pharmaceutical company in leading its nationwide anti-corruption program relating to bribery issues and improvement of its China compliance practices
Advised a US-based international medical device company on its commercial bribery investigations across the nation
Compliance in Other Sectors
Represented Anheuser-Busch InBev in compliance review and due diligence over a number of acquisition transactions in China
Assisted Anheuser-Busch InBev on a long-term basis in its daily compliance review of new vendors
Advised listed company Luyang Energy-Saving Materials Co., Ltd. on a retainer basis on compliance and risk management in all respects of its China operations
Assisted many US and Europe-based multinational companies in their China-based operations’ internal anti-bribery investigations and compliance programs
Advised many US and Europe-based multinational companies on the potential compliance issues concerning their China-based distribution systems and sales incentive programs
Provided anti-corruption and anti-bribery training to many multinational and domestic companies and advised on the compliance improvement program for their China-based operations
Provided nationwide legal support and assistance to many US and Europe-based multinational companies in governmental investigations on various compliance-related matters
Assisted a number of well-known US and Europe-based manufacturing corporations in a nationwide anti-counterfeit program
Advised a Europe-based international pharmaceuticals company on responding to investigations against its unfair competition violations across the nation
Represented a well-known Europe-based cosmetic company in a governmental investigation and improvement program relating to a severe safety accident
Represented a well-known US-based chemical company in a governmental investigation against its potential environmental violation issue
Honors and Awards
For Individual
Ranked Lawyer in the healthcare sector, Chambers Greater China Region Legal Guide, 2023-2025
Outstanding Writer (Compliance Sector), LexisNexis, 2021
Recommended in healthcare and life sciences sector, Legal 500 Asia-Pacific, 2020-2024
China 100 A-list lawyers, China Business Law Journal, 2016
Memberships & Affiliations
Member, All China Law Society and Shanghai Law Society
Certified Dealmaker of the PRC
Director, Professional Committee of Pharmaceutical and Healthcare Affairs, Shanghai Bar Association
Member, Life Science Law Committee, Shanghai Law Society
Member, Competition Law Committee, Shanghai Law Society
Legal Counsel and Deputy Director, Legal Affairs Center, Shanghai Medical Ethos Association
Legal Counsel, Shanghai Union Administration Office, Medical Affairs Organizations (the head office of Shanghai Medical Association, Shanghai Medical Doctor Association, Shanghai Association of Traditional Chinese Medicine, Shanghai Nursing Association, etc.)
Columnist, the compliance section of LexisNexis
Expert consultant, Supreme People's Procuratorate (for civil and administrative cases)
Legal Counsel, Government of Songjiang District, Shanghai
Invited Mediator, Professional People's Mediation Center of Pudong New Area, Shanghai
Publications
"Research and Proposal on Medical Expenses Bearing System during Major Epidemics" (awarded in the essay competition held by Healthcare Legal Service Special Group of All China Lawyers Association)
"Legitimate Handling of Medical Expenses During the Pandemic", official website of Shanghai Bar Association (selected in Compilation of Studies on Legal Issues Against the Pandemic in the Field of Medical and Healthcare by Medical and Health Committee of Shanghai Bar Association)
"Supervision and Legal Risks Regarding Online Diagnosis and Treatment", LexisNexis (also selected in The Great Health Industry: Policy, Trends, and Legal Innovations published by Law Press China)
"Updates for You: New Rules for Online Diagnosis and Hospital Management", Wolters Kluwer
"Compliance Manual for Anti-Commercial Bribery Practices", LexisNexis
Related
-
Articles Related
Data Collection and Processing: Health and Genetic Data (China)
An overview of the regulatory requirements for cybersecurity and data protection in the Chinese healthcare industry. It focuses on data compliance issues that might be encountered by pharmaceutical companies and medical institutions, in particular regarding the requirements on data localisation and cross-border transfers of various types of healthcare data, including sensitive personal information (PI), human genetic resources (HGR) data, clinical trial data, medical records, and so on.
2023-07-20 -
Deals Related
-
Events Related
-
Awards Related
Zhong Lun Garners 153 Honors across 40 Practice Areas in Chambers Greater China Region Guide 2025
Zhong Lun has received 153 accolades across 40 practice areas.
2025-02-17
-
Bar Admissions/Professional Qualifications
PRC Bar
Certified Dealmaker of the PRC -
Education
LL.M., University of Minnesota Law School, Minnesota, US
LL.B., East China University of Political Science and Law, Shanghai, China -
Professional Experience
Partner, Zhong Lun Law Firm
-
Languages
Chinese
English